Erika Garner-Spitzer

7PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Molecular targetsAllergyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 19, 2024
Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON).

Joshua Tobias, Marina Maglakelidze, Zoran Andrić

|May 25, 2024
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants.

Angelika Wagner, Erika Garner-Spitzer, Claudia Auer

|Jan 11, 2024
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion.

Joshua Tobias, Sandra Högler, Martin Raigel

|Dec 27, 2023
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance.

Nora Geissler, Maria Orola, Masoumeh Alinaghi

|Nov 26, 2022
Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer.

Joshua Tobias, Mirjana Drinić, Anna Schmid

|Sep 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.

Daniel Mrak, Daniela Sieghart, Elisabeth Simader

Pageof 2

Frequent Collaborators

5 joint publications

Ursula Wiedermann

4 joint publications

Michael Kundi

3 joint publications

Joshua Tobias

2 joint publications

Pia Gattinger